Phase 2 Study of Lorundrostat Alone or in Combination with Dapagliflozin in adults with HTN and CKD with Albuminuria

Protocol Name: Phase 2 Study of Lorundrostat Alone or in Combination with Dapagliflozin in adults with HTN and CKD with Albuminuria Sponsor: Mineralys Indication: Chronic Kidney Disease (CKD) Principal Investigator: Kim Rice, MD Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246

Phase 2 Study of Lorundrostat Alone or in Combination with Dapagliflozin in adults with HTN and CKD with Albuminuria Read More »